JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Laere, K.
Right arrow Articles by Dierckx, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Laere, K.
Right arrow Articles by Dierckx, R.
Journal of Nuclear Medicine Vol. 45 No. 6 933-942
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Statistical Parametric Mapping of 99mTc-ECD SPECT in Idiopathic Parkinson’s Disease and Multiple System Atrophy with Predominant Parkinsonian Features: Correlation with Clinical Parameters

Koen Van Laere, MD, PhD, DrSc1, Patrick Santens, MD, PhD2, Tommy Bosman, MD2, Jacques De Reuck, MD, PhD2, Luc Mortelmans, MD, PhD1 and Rudi Dierckx, MD, PhD3

1 Division of Nuclear Medicine, Leuven University Hospital, Leuven, Belgium
2 Department of Neurology, Ghent University Hospital, Ghent, Belgium
3 Division of Nuclear Medicine, Ghent University Hospital, Ghent, Belgium

Statistical parametric mapping was performed to investigate differences in regional cerebral blood flow (rCBF) between patients with idiopathic Parkinson’s disease (IPD), patients with multiple system atrophy (MSA), and healthy volunteers. In addition, a voxel-based covariance analysis was performed with disease-specific parameters and clinical patient data such as disease duration, medication, and clinical subscores. Methods: For this purpose, 99mTc-ethylcysteine dimer (ECD) SPECT was performed on 81 IPD patients (50 men, 31 women; age, 62.6 ± 10.2 y), 15 MSA patients (9 men, 6 women; age, 61.5 ± 9.2 y), and 44 age- and sex-matched healthy volunteers (27 men, 17 women; age, 59.2 ± 11.9 y). Results: Significant hypoperfusion was observed in IPD compared with healthy subjects in a symmetric subcortical-cortical network including the basal ganglia, thalami, prefrontal and lateral frontal cortex, and parietooccipital cortex (voxel P value Pheight < 0.001, corrected for multiple comparisons). For MSA, only symmetric hypoperfusion was seen in the putamen and thalamus with respect to healthy subjects and to IPD (Pheight < 0.01, corrected). Prolonged disease duration or higher Hoehn and Yahr stage results in hypoperfusion of the posterior associative cortex. There is a negative correlation between perfusion of the caudate heads and limbic system and the standardized dosage of dopamine agonists in the patients with PD, whereas for MSA a bilateral decrease in putamen activity was noted (Pheight < 0.001, uncorrected). Cognitive performance was positively correlated with limbic perfusion and inversely correlated with posterior associative cortical areas, but not with prefrontal regions. Conclusion: Voxel-based analysis of 99mTc-ECD perfusion SPECT shows detailed differences between IPD and MSA, which may be of use in the differentiation of both disease entities, and is able to elucidate cerebral perfusion correlates of disease severity, dopamine agonist medication, and cognitive performance.

Key Words: 99mTc-ECD SPECT • multiple system atrophy • Parkinson’s disease • statistical parametric mapping • anatomic standardization




This article has been cited by other articles:


Home page
Arch NeurolHome page
R. Cilia, C. Siri, G. Marotta, I. U. Isaias, D. De Gaspari, M. Canesi, G. Pezzoli, and A. Antonini
Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol, December 1, 2008; 65(12): 1604 - 1611.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Y. Kawai, M. Suenaga, A. Takeda, M. Ito, H. Watanabe, F. Tanaka, K. Kato, H. Fukatsu, S. Naganawa, T. Kato, et al.
Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P
Neurology, April 15, 2008; 70(16_Part_2): 1390 - 1396.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M J Firbank, S Molloy, I G McKeith, D J Burn, and J T O'Brien
Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1448 - 1451.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Scherfler, K. Seppi, E. Donnemiller, G. Goebel, C. Brenneis, I. Virgolini, G. K. Wenning, and W. Poewe
Voxel-wise analysis of [123I]{beta}-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease
Brain, July 1, 2005; 128(7): 1605 - 1612.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Hamaguchi, T. Kitamoto, T. Sato, H. Mizusawa, Y. Nakamura, M. Noguchi, Y. Furukawa, C. Ishida, I. Kuji, K. Mitani, et al.
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease
Neurology, February 22, 2005; 64(4): 643 - 648.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.